APO Research, Inc.

APO RESEARCH · REPORT

Azelastine

Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.

Product & engineering

Understand the product.

Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.

Azelastine is a medication primarily used as a nasal spray to treat hay fever and allergy symptoms including runny nose, sneezing, and itchy nose and as eye drops for allergic conjunctivitis. Other uses may include asthma and skin rashes for which is taken by mouth

Selected research

Industry Growth & Trends

Global Azelastine Industry Growth and Trends Forecast to 2032

Market perspective

Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.

Azelastine is a medication primarily used as a nasal spray to treat hay fever and allergy symptoms including runny nose, sneezing, and itchy nose and as eye drops for allergic conjunctivitis. Other uses may include asthma and skin rashes for which is taken by mouth

Global Azelastine includes Viatris, Apotex, Yunfeng Pharma, Sun Pharma, Amneal Pharmaceuticals, Zhongsheng Pharma, Hikma Pharmaceuticals, Perrigo, Alkem Labs and Jiangxi Zhenshiming Pharmaceutical, etc. Global top 3 companies hold a share over 57%. Asia-Pacific is the largest market, with a share about 40%, followed by Europe and North America with the share approximately 20% each.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Azelastine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Azelastine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Azelastine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Azelastine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Azelastine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Azelastine Market by Company

Viatris

Apotex

Yunfeng Pharma

Sun Pharma

Amneal Pharmaceuticals

Zhongsheng Pharma

Hikma Pharmaceuticals

Perrigo

Alkem Labs

Jiangxi Zhenshiming Pharmaceutical

Azelastine Segment by Type

Nasal Spray

Eye Drops

Others

Azelastine Segment by Distribution Channel

Hospital

Retail Pharmacy

Others

Azelastine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azelastine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azelastine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azelastine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Azelastine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Azelastine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nasal Spray Table 2. Major Company of Eye Drops Table 3. Major Company of Others Table 4. Global Azelastine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Azelastine Sales by Type (2021-2026) & (K Units) Table 6. Global Azelastine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Azelastine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Azelastine Sales Market Share in Value by Type (2021-2026) Table 9. Global Azelastine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Azelastine Sales by Type (2027-2032) & (K Units) Table 11. Global Azelastine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Azelastine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Azelastine Sales Market Share in Value by Type (2027-2032) Table 14. Global Azelastine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Azelastine Sales by Type (2021-2026) & (K Units) Table 16. North America Azelastine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Azelastine Sales by Type (2021-2026) & (K Units) Table 18. Europe Azelastine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Azelastine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Azelastine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Azelastine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Azelastine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Azelastine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Azelastine Sales by Type (2021-2026) & (US$ Million) Table 25. Azelastine Industry Trends Table 26. Azelastine Industry Drivers Table 27. Azelastine Industry Opportunities and Challenges Table 28. Azelastine Industry Restraints Table 29. Global Azelastine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Azelastine Revenue Market Share by Company (2021-2026) Table 31. Global Azelastine Sales by Company (2021-2026) & (K Units) Table 32. Global Azelastine Sales Share by Company (2021-2026) Table 33. Global Azelastine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Azelastine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Azelastine Major Company Production Sites and Headquarters Table 36. Global Azelastine Company, Product Type & Application Table 37. Global Azelastine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Azelastine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Azelastine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Azelastine Sales by Region (2021-2026) & (K Units) Table 42. Global Azelastine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Azelastine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Azelastine Sales Market Share in Value by Region (2021-2026) Table 45. Global Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Azelastine Sales by Region (2027-2032) & (K Units) Table 47. Global Azelastine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Azelastine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Azelastine Sales Market Share in Value by Region (2027-2032) Table 50. Global Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Azelastine Sales by Distribution Channel (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Azelastine Sales by Distribution Channel (2021-2026) & (K Units) Table 53. Global Azelastine Sales Market Share in Volume by Distribution Channel (2021-2026) Table 54. Global Azelastine Sales by Distribution Channel (2021-2026) & (US$ Million) Table 55. Global Azelastine Sales Market Share in Value by Distribution Channel (2021-2026) Table 56. Global Azelastine Price by Distribution Channel (2021-2026) & (US$/Unit) Table 57. Global Azelastine Sales by Distribution Channel (2027-2032) & (K Units) Table 58. Global Azelastine Sales Market Share in Volume by Distribution Channel (2027-2032) Table 59. Global Azelastine Sales by Distribution Channel (2027-2032) & (US$ Million) Table 60. Global Azelastine Sales Market Share in Value by Distribution Channel (2027-2032) Table 61. Global Azelastine Price by Distribution Channel (2027-2032) & (US$/Unit) Table 62. North America Azelastine Sales by Distribution Channel (2021-2026) & (K Units) Table 63. North America Azelastine Sales by Distribution Channel (2021-2026) & (US$ Million) Table 64. Europe Azelastine Sales by Distribution Channel (2021-2026) & (K Units) Table 65. Europe Azelastine Sales by Distribution Channel (2021-2026) & (US$ Million) Table 66. Asia-Pacific Azelastine Sales by Distribution Channel (2021-2026) & (K Units) Table 67. Asia-Pacific Azelastine Sales by Distribution Channel (2021-2026) & (US$ Million) Table 68. Latin America Azelastine Sales by Distribution Channel (2021-2026) & (K Units) Table 69. Latin America Azelastine Sales by Distribution Channel (2021-2026) & (US$ Million) Table 70. Middle East and Africa Azelastine Sales by Distribution Channel (2021-2026) & (K Units) Table 71. Middle East and Africa Azelastine Sales by Distribution Channel (2021-2026) & (US$ Million) Table 72. Viatris Company Information Table 73. Viatris Business Overview Table 74. Viatris Azelastine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Viatris Azelastine Product Portfolio Table 76. Viatris Recent Development Table 77. Apotex Company Information Table 78. Apotex Business Overview Table 79. Apotex Azelastine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Apotex Azelastine Product Portfolio Table 81. Apotex Recent Development Table 82. Yunfeng Pharma Company Information Table 83. Yunfeng Pharma Business Overview Table 84. Yunfeng Pharma Azelastine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Yunfeng Pharma Azelastine Product Portfolio Table 86. Yunfeng Pharma Recent Development Table 87. Sun Pharma Company Information Table 88. Sun Pharma Business Overview Table 89. Sun Pharma Azelastine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sun Pharma Azelastine Product Portfolio Table 91. Sun Pharma Recent Development Table 92. Amneal Pharmaceuticals Company Information Table 93. Amneal Pharmaceuticals Business Overview Table 94. Amneal Pharmaceuticals Azelastine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Amneal Pharmaceuticals Azelastine Product Portfolio Table 96. Amneal Pharmaceuticals Recent Development Table 97. Zhongsheng Pharma Company Information Table 98. Zhongsheng Pharma Business Overview Table 99. Zhongsheng Pharma Azelastine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Zhongsheng Pharma Azelastine Product Portfolio Table 101. Zhongsheng Pharma Recent Development Table 102. Hikma Pharmaceuticals Company Information Table 103. Hikma Pharmaceuticals Business Overview Table 104. Hikma Pharmaceuticals Azelastine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Hikma Pharmaceuticals Azelastine Product Portfolio Table 106. Hikma Pharmaceuticals Recent Development Table 107. Perrigo Company Information Table 108. Perrigo Business Overview Table 109. Perrigo Azelastine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Perrigo Azelastine Product Portfolio Table 111. Perrigo Recent Development Table 112. Alkem Labs Company Information Table 113. Alkem Labs Business Overview Table 114. Alkem Labs Azelastine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Alkem Labs Azelastine Product Portfolio Table 116. Alkem Labs Recent Development Table 117. Jiangxi Zhenshiming Pharmaceutical Company Information Table 118. Jiangxi Zhenshiming Pharmaceutical Business Overview Table 119. Jiangxi Zhenshiming Pharmaceutical Azelastine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Jiangxi Zhenshiming Pharmaceutical Azelastine Product Portfolio Table 121. Jiangxi Zhenshiming Pharmaceutical Recent Development Table 122. North America Azelastine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Azelastine Sales by Country (2021-2026) & (K Units) Table 124. North America Azelastine Sales Market Share by Country (2021-2026) Table 125. North America Azelastine Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Azelastine Sales Market Share Forecast by Country (2027-2032) Table 127. North America Azelastine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Azelastine Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Azelastine Market Share by Country (2021-2026) Table 130. North America Azelastine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Azelastine Market Share Forecast by Country (2027-2032) Table 132. Europe Azelastine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Azelastine Sales by Country (2021-2026) & (K Units) Table 134. Europe Azelastine Sales Market Share by Country (2021-2026) Table 135. Europe Azelastine Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Azelastine Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Azelastine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Azelastine Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Azelastine Market Share by Country (2021-2026) Table 140. Europe Azelastine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Azelastine Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Azelastine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Azelastine Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Azelastine Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Azelastine Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Azelastine Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Azelastine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Azelastine Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Azelastine Market Share by Country (2021-2026) Table 150. Asia-Pacific Azelastine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Azelastine Market Share Forecast by Country (2027-2032) Table 152. Latin America Azelastine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Azelastine Sales by Country (2021-2026) & (K Units) Table 154. Latin America Azelastine Sales Market Share by Country (2021-2026) Table 155. Latin America Azelastine Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Azelastine Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Azelastine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Azelastine Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Azelastine Market Share by Country (2021-2026) Table 160. Latin America Azelastine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Azelastine Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Azelastine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Azelastine Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Azelastine Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Azelastine Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Azelastine Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Azelastine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Azelastine Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Azelastine Market Share by Country (2021-2026) Table 170. Middle East and Africa Azelastine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Azelastine Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Azelastine Distributors List Table 175. Azelastine Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Azelastine Image Figure 2. Global Azelastine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azelastine Market Size (2021-2032) & (US$ Million) Figure 4. Global Azelastine Sales (2021-2032) & (K Units) Figure 5. Nasal Spray Image Figure 6. Global Nasal Spray Sales YoY Growth (2021-2032) & (K Units) Figure 7. Eye Drops Image Figure 8. Global Eye Drops Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Azelastine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Azelastine Market Share by Type 2025 VS 2032 Figure 13. North America Azelastine Sales Market Share in Volume by Type in 2025 Figure 14. North America Azelastine Sales Market Share in Value by Type in 2025 Figure 15. Europe Azelastine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Azelastine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Azelastine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Azelastine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Azelastine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Azelastine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Azelastine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Azelastine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Azelastine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Azelastine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Azelastine Market Share by Application 2025 VS 2032 Figure 33. North America Azelastine Sales Market Share in Volume by Application in 2025 Figure 34. North America Azelastine Sales Market Share in Value by Application in 2025 Figure 35. Europe Azelastine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Azelastine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Azelastine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Azelastine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Azelastine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Azelastine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Azelastine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Azelastine Sales Market Share in Value by Application in 2025 Figure 43. North America Azelastine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Azelastine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Azelastine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Azelastine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Azelastine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Azelastine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Azelastine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Azelastine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Azelastine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Azelastine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Azelastine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Azelastine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Azelastine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Azelastine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Azelastine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Azelastine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Azelastine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Azelastine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Azelastine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Azelastine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Azelastine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Azelastine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Spray
  • Eye Drops
  • Others
Applications
  • Hospital
  • Retail Pharmacy
  • Others
Companies covered
  • Viatris
  • Apotex
  • Yunfeng Pharma
  • Sun Pharma
  • Amneal Pharmaceuticals
  • Zhongsheng Pharma
  • Hikma Pharmaceuticals
  • Perrigo
  • Alkem Labs
  • Jiangxi Zhenshiming Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Azelastine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Azelastine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Azelastine Market by Type
  6. 1.3.1 Nasal Spray
  7. 1.3.2 Eye Drops
  8. 1.3.3 Others
  9. 1.4 Global Azelastine Market Size by Type
  10. 1.4.1 Global Azelastine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Azelastine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Azelastine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Azelastine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Azelastine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Azelastine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Azelastine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Azelastine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Azelastine Industry Trends
  2. 2.2 Azelastine Industry Drivers
  3. 2.3 Azelastine Industry Opportunities and Challenges
  4. 2.4 Azelastine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Azelastine Revenue (2021-2026)
  2. 3.2 Global Top Players by Azelastine Sales (2021-2026)
  3. 3.3 Global Top Players by Azelastine Price (2021-2026)
  4. 3.4 Global Azelastine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Azelastine Major Company Production Sites & Headquarters
  6. 3.6 Global Azelastine Company, Product Type & Application
  7. 3.7 Global Azelastine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Azelastine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Azelastine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Azelastine Tier 1, Tier 2, and Tier 3
4 Azelastine Regional Status and Outlook
  1. 4.1 Global Azelastine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Azelastine Historic Market Size by Region
  3. 4.2.1 Global Azelastine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Azelastine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Azelastine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Azelastine Forecasted Market Size by Region
  7. 4.3.1 Global Azelastine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Azelastine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Azelastine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Azelastine by Application
  1. 5.1 Azelastine Market by Distribution Channel
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Azelastine Market Size by Distribution Channel
  6. 5.2.1 Global Azelastine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Azelastine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Azelastine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Distribution Channel
  10. 5.3.1 North America Azelastine Sales Breakdown by Distribution Channel (2021-2026)
  11. 5.3.2 Europe Azelastine Sales Breakdown by Distribution Channel (2021-2026)
  12. 5.3.3 Asia-Pacific Azelastine Sales Breakdown by Distribution Channel (2021-2026)
  13. 5.3.4 South America Azelastine Sales Breakdown by Distribution Channel (2021-2026)
  14. 5.3.5 Middle East and Africa Azelastine Sales Breakdown by Distribution Channel (2021-2026)
6 Company Profiles
  1. 6.1 Viatris
  2. 6.1.1 Viatris Company Information
  3. 6.1.2 Viatris Business Overview
  4. 6.1.3 Viatris Azelastine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Viatris Azelastine Product Portfolio
  6. 6.1.5 Viatris Recent Developments
  7. 6.2 Apotex
  8. 6.2.1 Apotex Company Information
  9. 6.2.2 Apotex Business Overview
  10. 6.2.3 Apotex Azelastine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Apotex Azelastine Product Portfolio
  12. 6.2.5 Apotex Recent Developments
  13. 6.3 Yunfeng Pharma
  14. 6.3.1 Yunfeng Pharma Company Information
  15. 6.3.2 Yunfeng Pharma Business Overview
  16. 6.3.3 Yunfeng Pharma Azelastine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Yunfeng Pharma Azelastine Product Portfolio
  18. 6.3.5 Yunfeng Pharma Recent Developments
  19. 6.4 Sun Pharma
  20. 6.4.1 Sun Pharma Company Information
  21. 6.4.2 Sun Pharma Business Overview
  22. 6.4.3 Sun Pharma Azelastine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sun Pharma Azelastine Product Portfolio
  24. 6.4.5 Sun Pharma Recent Developments
  25. 6.5 Amneal Pharmaceuticals
  26. 6.5.1 Amneal Pharmaceuticals Company Information
  27. 6.5.2 Amneal Pharmaceuticals Business Overview
  28. 6.5.3 Amneal Pharmaceuticals Azelastine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Amneal Pharmaceuticals Azelastine Product Portfolio
  30. 6.5.5 Amneal Pharmaceuticals Recent Developments
  31. 6.6 Zhongsheng Pharma
  32. 6.6.1 Zhongsheng Pharma Company Information
  33. 6.6.2 Zhongsheng Pharma Business Overview
  34. 6.6.3 Zhongsheng Pharma Azelastine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zhongsheng Pharma Azelastine Product Portfolio
  36. 6.6.5 Zhongsheng Pharma Recent Developments
  37. 6.7 Hikma Pharmaceuticals
  38. 6.7.1 Hikma Pharmaceuticals Company Information
  39. 6.7.2 Hikma Pharmaceuticals Business Overview
  40. 6.7.3 Hikma Pharmaceuticals Azelastine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hikma Pharmaceuticals Azelastine Product Portfolio
  42. 6.7.5 Hikma Pharmaceuticals Recent Developments
  43. 6.8 Perrigo
  44. 6.8.1 Perrigo Company Information
  45. 6.8.2 Perrigo Business Overview
  46. 6.8.3 Perrigo Azelastine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Perrigo Azelastine Product Portfolio
  48. 6.8.5 Perrigo Recent Developments
  49. 6.9 Alkem Labs
  50. 6.9.1 Alkem Labs Company Information
  51. 6.9.2 Alkem Labs Business Overview
  52. 6.9.3 Alkem Labs Azelastine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alkem Labs Azelastine Product Portfolio
  54. 6.9.5 Alkem Labs Recent Developments
  55. 6.10 Jiangxi Zhenshiming Pharmaceutical
  56. 6.10.1 Jiangxi Zhenshiming Pharmaceutical Company Information
  57. 6.10.2 Jiangxi Zhenshiming Pharmaceutical Business Overview
  58. 6.10.3 Jiangxi Zhenshiming Pharmaceutical Azelastine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jiangxi Zhenshiming Pharmaceutical Azelastine Product Portfolio
  60. 6.10.5 Jiangxi Zhenshiming Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Azelastine Sales by Country
  2. 7.1.1 North America Azelastine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Azelastine Sales by Country (2021-2026)
  4. 7.1.3 North America Azelastine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Azelastine Market Size by Country
  6. 7.2.1 North America Azelastine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Azelastine Market Size by Country (2021-2026)
  8. 7.2.3 North America Azelastine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Azelastine Sales by Country
  2. 8.1.1 Europe Azelastine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Azelastine Sales by Country (2021-2026)
  4. 8.1.3 Europe Azelastine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Azelastine Market Size by Country
  6. 8.2.1 Europe Azelastine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Azelastine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Azelastine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Azelastine Sales by Country
  2. 9.1.1 Asia-Pacific Azelastine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Azelastine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Azelastine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Azelastine Market Size by Country
  6. 9.2.1 Asia-Pacific Azelastine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Azelastine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Azelastine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Azelastine Sales by Country
  2. 10.1.1 South America Azelastine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Azelastine Sales by Country (2021-2026)
  4. 10.1.3 South America Azelastine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Azelastine Market Size by Country
  6. 10.2.1 South America Azelastine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Azelastine Market Size by Country (2021-2026)
  8. 10.2.3 South America Azelastine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Azelastine Sales by Country
  2. 11.1.1 Middle East and Africa Azelastine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Azelastine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Azelastine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Azelastine Market Size by Country
  6. 11.2.1 Middle East and Africa Azelastine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Azelastine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Azelastine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Azelastine Value Chain Analysis
  2. 12.1.1 Azelastine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Azelastine Production Mode & Process
  7. 12.2 Azelastine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Azelastine Distributors
  10. 12.2.3 Azelastine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.